Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation at its upcoming annual meeting, citing concerns about certain changes made to long-term ...

Institutional Shareholder Services has recommended Pfizer investors ... and undermine a “pay-for-performance philosophy,” ISS said. Annual incentives for executives are tied to achieving ...

Donald Trump takes biopharma on a tariff-themed rollercoaster ride; J&J kicks off the Q1 earnings season; experts express concern about the FDA’s future; Pfizer’s obesity setback could be Viking’s ...

The proxy adviser said on Wednesday that the changes added about $1 million in additional value for CEO. The modification "significantly undermines the at-risk nature of the awards and a ...